| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
TAR
|
Nathaniel Kevin Mullin
|
||||||
| GSE244786 |
CRISPRi mediated treatment of dominant rhodopsin-associated retinitis pigmentosa.
|
4 |
|
Nathaniel Kevin Mullin | Mar 28, 2024 |
